Company page
Anaptysbio, Inc.
Anaptysbio, Inc. is a public biotechnology company based in the United States, trading under the ticker ANAB. The company has a market capitalization of approximately $1.67 billion. Anaptysbio focuses on developing innovative therapies to address unmet medical needs.
- Ticker
- ANAB:NASDAQ
- Asset type
- Stock
- Market cap
- $1.67B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD